ketanserin has been researched along with cyclosporine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bariety, J; Darlametsos, I; Gkikas, G; Hornych, A; Morphake, P; Papanikolaou, N; Tsipas, G | 1 |
| Bariety, J; Bokas, S; Darlametsos, I; Gkika, EL; Gkikas, G; Hornych, A; Karageorgou, I; Morphake, P; Papanikolaou, N; Patsialos, K; Tsipas, G | 1 |
| Blanckaert, P; Burvenich, I; De Bruyne, S; De Vos, F; Moerman, L; Staelens, S; Wyffels, L | 1 |
| Blanckaert, PB; Burvenich, I; De Bruyne, S; De Vos, F; Moerman, L; Wyffels, L | 1 |
| Bauer, A; Beer, S; Celik, AA; Elmenhorst, D; Kroll, T; Matusch, A; Wedekind, F; Weisshaupt, A | 1 |
11 other study(ies) available for ketanserin and cyclosporine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of ketanserine in cyclosporine-induced renal dysfunction in rats.
Topics: Animals; Body Weight; Creatinine; Cyclosporine; Female; Immunosuppressive Agents; Ketanserin; Kidney; Prostaglandins; Proteinuria; Rats; Rats, Wistar; Serotonin Antagonists; Thromboxane A2 | 1995 |
Effects of OKY-046 and nifedipine in cyclosporine-induced renal dysfunction in rats.
Topics: Animals; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Interactions; Eicosanoids; Enzyme Inhibitors; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Immunosuppressive Agents; Ketanserin; Kidney Function Tests; Kidney Tubules; Linoleic Acids; Metabolic Clearance Rate; Methacrylates; Nifedipine; Oenothera biennis; Plant Oils; Rats; Rats, Wistar; Renal Insufficiency | 1996 |
Effect of cyclosporin A administration on the biodistribution and multipinhole muSPECT imaging of [123I]R91150 in rodent brain.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Cyclosporine; Iodine Radioisotopes; Ketanserin; Ligands; Male; Mice; Piperidines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2009 |
In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptor.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Cyclosporine; Iodine Radioisotopes; Ketanserin; Male; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2008 |
[¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Blood-Brain Barrier; Brain; Cyclosporine; Fluorine Radioisotopes; Ketanserin; Ligands; Positron-Emission Tomography; Protein Transport; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A | 2014 |